Expression of granulysin in polymyositis and inclusion-body myositis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 10, 2006, Pages 1187-1190

  Ikezoe, K ^a   Ohshima, S ^a   Osoegawa, M ^a   Tanaka, M ^a   Ogawa, K ^b   Nagata, K ^b   Kira, J I ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b BML   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GRANULYSIN; PERFORIN;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL;

ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DRUG RESISTANCE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; STEROIDS;

EID: 33749020859     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.081810     Document Type: Article

References (22)

1. Kogi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994;369:31-7.
2. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003;3:361-70.
3. Pena SV, Krensky AM. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 1997;9:117-25.
4. Dieli F, Troye-Blomberg M, Ivanyi J, et al. Granulysin-dependent killing of intracellular and extracellular Mycobocterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 2001;184:1082-5.
5. Gamen S, Hanson DA, Kaspar A, et al. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998;61:1758-64.
6. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
7. Orimo S, Koga R, Goto K, et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994;4:219-26.
8. Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1997;97:2905-10.
9. Thomas MW III. Ch16 Disease of nerve and muscle: polymyositis. In: Martin AS, eds. Manual of neurologic therapeutics. 6th edn. Philadelphia: Lippincolt Williams & Wilkins, 1999:411.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
11. van der Meulen MFG, Bronner IM, Hoogendijk JE, et al. Polymyositis. An overdiagnosed entity. Neurology 2003;61:316-21.
12. Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998;10:530-4.
13. van der Meulen MFG, Hoogendijk JE, Moons KGM, et al. Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis. Neuromuscul Disord 2001;11:447-51.
14. Ogowa K, Takamori Y, Suzuki K, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol 2003;33:1925-33.
15. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. V: identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 1988;23:493-9.
16. Mantegazza R, Andreetta F, Bernasconi P, et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest 1993;91:2880-6.
17. Benveniste O, Herson S, Salomon B, et al. Long-term persistence of clonally expanded T cells in patients with polymyositis. Ann Neurol 2004;56:867-72.
18. Ochoa MT, Stenger S, Sieling PA, et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001;7:174-9.
19. Ma LL, Wang CLC, Neely GG, et al. NK cells use perform rather than granulysin for anticryptococcal activity. J Immunol 2004;173:3357-65.
20. Figarella-Branger O, Pellissier JF, Bianco N, et al. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol (Berl) 1990;79:528-36.
21. Vattemi G, Engel WK, McFerrin J, et al. Endoplasmic reticulum stress and unfolded response in inclusion body myositis muscle. Am J Pathol 2004;164:1-7.
22. Sarwal MM, Jani A, Chang S, et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001;62:21-31.